Oct 17 (Reuters) - Prophase Labs Inc :
* PROPHASE LABS ANNOUNCES POSITIVE UPDATES ON STRATEGIC INITIATIVES COMPANY ANTICIPATES MULTIPLE LIQUIDITY EVENTS IN H1 2025
* PROPHASE LABS INC - STRATEGIC PARTNERSHIP DISCUSSIONS BEGIN FOR BE-SMART ESOPHAGEAL CANCER TEST
* PROPHASE LABS INC - PMI SALE TARGETED FOR EARLY 2025, PROJECTED VALUE $40+ MILLION
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.